Genetic variation in the apolipoprotein H (β2-glycoprotein I) gene affects plasma apolipoprotein H concentrations

Human Genetics

Volumn 105, Issue 1-2, 1999, Pages 63-71

  Mehdi, Haider ^a   Aston, Christopher E ^a   Sanghera, Dharambir K ^a   Hamman, Richard F ^b   Kamboh, M Ilyas ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA2 GLYCOPROTEIN 1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CODON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADULT; AGED; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CHOLESTEROL, HDL; CODON; COLORADO; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; THROMBOSIS; VARIATION (GENETICS);

EID: 0032789510     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390051065     Document Type: Article

References (68)

1. Aoyama Y, Chan YL, Wool IG (1989) The primary structure of rat β2-glycoprotein I. Nucleic Acids Res 17:6401
2. Arvieux J, Roussel B, Ponard D, Colomb MG (1994) IgG2 subclass restriction of anti-β2-glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 95:310-315
3. Atkin J, Rundle AJ (1974) Serum β2-glycoprotein 1 phenotype frequencies in an English population. Humangenetik 21:81-84
4. Banci LF, JMM, VanderLinden IK, Bertina RM (1992) β2-glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 67:649-653
5. Cabiedes J, Cabral AR, Alarcon-Segovia D (1995) Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 22:1899-1906
6. Cabral AR, Cabiedes J, Alarcon-Segovia D, Sanchez-Guerrero J (1992) Phospholipid specificity and requirement of β2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome. J Autoimmun 5:787-801
7. Cassader M, Ruin G, Gambino R, Guzzon F, Dagano A, Vegalia F, Pagni R, Pagano G (1994) Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis 110: 45-51
8. Cassader M, Ruiu G, Gambino R, Veglia F, Pagano G (1997) Apolipoprotein H levels in diabetic subjects: correlation with cholesterol levels. Metabolism 46:522-525
9. Cleve H (1968) Genetic studies on the deficiency of β2-glycoprotein I of human serum. Hum Genet 5:294-304
10. Davie EW, Ichinose A, Leytus SP (1986) Structural features of the proteins participating in blood coagulation and fibrinolysis. Cold Spring Harb Symp Quant Biol 51:509-514
11. Eichner JE, Kuller LH, Kamboh MI, Ferrell RE (1989) Phenotypic effects of apolipoproteins structure variation on lipid profiles. I. APOH and quantitative lipid measures in the Healthy Women Study. Genet Epidemiol 6:311-318
12. Galli M, Comfurius P, Maassen C, Hemker HC, DeBaets MH, Breda-Vriesman PLC van, Barbui T, Zwaal RFA, Bevers EM (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544-1547
13. Galli M, Cortelazzo S, Daldossi M, Barbui T (1992) Increased levels of β2-glycoprotein I (aca-cofactor) in patients with lupus anticoagulant. Thromb Haemost 67:386
14. Halkier T, Magnussen S (1988) Contact activation of blood coagulation is inhibited by plasma factor XIIIb-chain. Thromb Res 51:313-324
15. Hamman RF, Marshal JA, Baxter J, Kahn LR, Mayer EJ, Dolean M, Murphy JR, Lezotte DC (1989) Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: The San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311
16. Hoeg JM, Segal P, Gregg RE, Chang YS, Lindgren FT, Adamson GL, Frank M, Brickman C, Brewer HB Jr (1985) Characterization of plasma lipids and lipoproteins in patients with β2-glycoprotein I (apolipoprotein H) deficiency. Atherosclerosis 55: 25-34
17. Hunt J, Krilis S (1994) The fifth domain of β2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol 152: 653-659
18. Hunt J, Simpson RJ, Krilis S (1993) Identification of a region of β2-glycoprotein I critical for lipid-binding and anticardiolipin antibody cofactor activity. Proc Natl Acad Sci USA 90:2141-2145
19. Ichinose A, Bottenus RE, Davie EW (1990) Structure of transglutaminases. J Biol Chem 265:13411-13414
20. Jones JV, James H, Tan MH, Mansor M (1992) Antiphospholipid antibodies required β2-glycoprotein I (apolipoprotein H) as co-factor. J Rheumatol 19:1397-1402
21. Kamboh MI, Ferrell RE, Sepehrnia B (1988) Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (β2-glycoprotein I). Am J Hum Genet 42:452-457
22. Kamboh MI, Wagenknecht DR, McIntyre J (1995) Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipid. Hum Genet 95:385-388
23. Kamboh MI, Crawford MH, Aston CE, Leonard WR (1996) Population distributions of APOE, APOH and APOA4 polymorphisms and their relationship with quantitative plasma lipid levels among the Evenki Herders of Siberia. Hum Biol 68: 231-243
24. Kamboh MI, Rewers M, Aston CE, Hamman RF (1997) Plasma apolipoprotein A-I, apolipoprotein B, and lipoprotein (a) concentrations in normoglycemic Hispanics and non-Hispanic Whites from the San Luis Valley, Colorado. Am J Epidemiol 146:1011-1018
25. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF (1991) Effects of polymorphisms in apolipoproteins E, A-IV and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11:1330-1348
26. Kato H, Enjyoji KI (1991) Amino acid sequence and location of the disulfide bonds in bovine β2-glycoprotein I: the presence of five sushi domains. Biochemistry 30:1687-1694
27. Klaerke DA, Rojkjaer R, Christensen L, Schousboe I (1997) Identification of β2-glycoprotein I as a membrane-associated protein in kidney: purification by calmodulin affinity chromatography. Biochim Biophys Acta 1339:203-216
28. Klickenstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, Fearon DT (1987) Human C3b/C4b receptor (CR1) demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins. J Exp Med 165:2095-1112
29. Koppe AI, Walter H, Chopra VP, Bajatzadeh M (1970) Investigation on the genetics and population genetics of the β2-glycoprotein I polymorphism. Hum Genet 9:164-171
30. Kristensen T, Deustachio P, Ogato RT, Chung LP, Reid KBM, Tack BF (1987) The superfamily of C3b/C4b-binding proteins. Fed Proc 46:2463-2469
31. Kristensen T, Schousboe I, Boel E, Mulvihill EM, Hansen RR, Moller KB, Moller NPH, Sottrup-Jensen L (1991) Molecular cloning and mammalian expression of human β2-glycoprotein I cDNA. FEBS Lett 289:183-186
32. Kroll J, Larsen JK, Loft H, Ezban M, Wallewik K, Faber M (1976) DNA binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta 434:490-501
33. Lauer SA, Hempel U, Cries, A, Frank K-H (1993) Amino acid sequence of the region of β2-glycoprotein I (gp I) which mediates binding of autoantibodies to the cardiolipin-gp I complex in humans. Immunology 80:22-28
34. Lozier J, Takahashi N, Putnam FW (1984) Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci USA 81:3640-3644
35. McNally T, Mackie IJ, Isenberg DA, Machin SJ (1993) Immuno-electrophoresis and ELISA techniques for assay of plasma β2-glycoprotein-I and the influence of plasma lipids. Thromb Res 72:275-286
36. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87: 4120-4124
37. Mehdi H, Nunn M, Steel DM, Whitehead AS, Perez M, Walker L, Peeples ME (1991) Nucleotide sequence and expression of the human gene encoding apolipoprotein H. Gene 108:293-298
38. Mehdi H, Kaplan MJ, Anlar FY, Yang X, Bayer R, Sutherland K, Peeples ME (1994) Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 68:2415-2424
39. Mehdi H, Yang X, Peeples ME (1996) An altered form of apolipo-protein H binds hepatitis B virus surface antigen most efficiently. Virology 217:58-66
40. Nakaya Y, Schaefer EJ, Brewer HB Jr (1980) Activation of human post heparin lipoprotein lipase by apolipoprotein H (β2-glycoprotein I). Biochem Biophys Res Commun 95:1168-1172
41. Nimpf J, Bevers EM, Bomans PHH, Till U, Wurm H, Kostner GM, Zwaal RFA (1986) Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochim Biophys Acta 884:142-149
42. Okkels H, Rasmussen TE, Sanghera DK, Kamboh MI, Kristensen T (1999) Structure of the human β2-glycoprotein I (apolipo-protein H) gene. Eur J Biochem 259:435-440
43. Costing J, Derksen R, Entjes H, Bouma B, Broot P (1992) Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein I. Thromb Haemost 67:499-502
44. Polz E, Kostner GM (1979a) The binding of β2-glycoprotein I to human serum lipoproteins: distribution among density fractions. FEBS Lett 102: 183-186
45. Polz E, Kostner GM (1979b) Binding of β2-glycoprotein I to intralipid: distribution of the dissociation constant. Biochem Biophys Res Commun 90:1305-1312
46. Polz E, Wurm H, Kostner GM (1980) Investigations on β2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 11:265-270
47. Propert DN (1978) The relationship of sex, smoking status, birth rank and parental age to β2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults. Hum Genet 43:281-288
48. Rewers M, Shetterly SM, Hoag S, Marshall J, Hamman RF (1993) Is the risk of coronary heart disease lower in Hispanics than in non-Hispanic Whites? The San Luis Valley Diabetes Study. Ethn Dis 3:44-54
49. Rojkjaer R, Klaerke DA, Schousboe I (1997) Characterization of the interaction between β2-glycoprotein I and calmodulin, and identification of a binding sequence in β2-glycoprotein I. Biochem Biophys Acta 1339:217-225
50. Ruiu G, Gambino RG, Veglia F, Pagano G, Cassader M (1997) Influence of APOH protein polymorphism on apoH levels in normal and diabetic subjects. Clin Genet 52:167-172
51. Sana N, Kamboh MI, Ahn YI, Tay JSH, Ferrell RE (1993) Influence of the apolipoprotein H polymorphism on serum lipoprotein and apolipoprotein levels in two Asian populations. Ethn Dis 3:250-254
52. Sanghera DK, Wagenknecht DR, McIntyre JA, Kamboh MI (1997 a) Identification of structural mutations in the fifth domain of apolipoprotein H (β2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 6:311-316
53. Sanghera DK, Kristensen T, Hamman RF, Kamboh MI (1997b) Molecular basis of the apolipoprotein H (β2-glycoprotein I) protein polymorphism. Hum Genet 100:57-62
54. Schousboe I (1979) Purification, characterization and identification of an agglutinin in human serum. Biochim Biophys Acta 579:396-408
55. Schousboe I (1980) Binding of β2-glycoprotein I to platelets: effect on adenylate cyclase activity. Thromb Res 19:225-237
56. Schousboe I (1985) β2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66:1086-1091
57. Schousboe I (1988) In vitro activation of the contact activation system (Hageman factor system) in plasma by acidic phospholipids, and the inhibitory effect of β2-glycoprotein I on the activation. Int J Biochem 20:309-315
58. Schousboe I, Rasmussen MS (1988) The effect of β2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation. Int J Biochem 20:787-792
59. Schultz HE, Heide K, Haupt H (1961) Uber ein bisher unbekanntes neidermolekul es β2-Globulin des Humanserums. Naturwissenschaften 48:719
60. Sepehrnia B, Kamboh MI, Adams-Campbell LL, Bunker CH, Nwankwo M, Majumder PP, Ferrell RE (1989) Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations. Hum Genet 82:118-122
61. Sheng Y, Sali A, Herzog H, Lahnstein J, Krilis SA (1996) Site-directed mutagenesis of recombinant human β2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 157:3744-3751
62. Stefas E, Rucheton M, Graafland H, Moynier M, Sompeyrac C, Bahraoui EM, Veas F (1997) Human plasmatic apolipoprotein H binds human immunodeficiency virus type 1 and type 2 proteins. AIDS Res Hum Reteroviruses 13:97-104
63. Steinkasserer A, Estaller C, Weiss E, Sim RB (1991) Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I. Biochem J 277:387-391
64. Steinkasserer A, Dorner C, Wurzner R, Sim RB (1993) Human β2-glycoprotein I: molecular analysis of DNA and amino acid polymorphism. Hum Genet 91:401-402
65. Templeton AR (1987) The general relationship between average effect and average excess. Genet Res Comb 49:69-70
66. Walter H, Hilling M, Brachtel R, Hitzeroth HW (1979) On the population genetics of β2-glycoprotein I. Hum Hered 29: 236-241
67. Wang MX, Kandiah DA, Ichikawa K, Khamashta M, Hughes G, Koike T, Roubey R, Krilis SA (1995) Epitope specificity of monoclonal anti-β2-glycoprotein I antibodies derived from patients with antiphospholipid syndrome. J Immunol 155:1629-1639
68. Wurm H (1984) β2-Glycoprotein I (apolipoprotein H) interactions with phospholipids vesicles. Int J Biochem 16:511-515